Immunohistochemistry staining of the breast tumors demonstrated that doxycycline treatment significantly decreased the numbers of F4/80+ macrophages by ~50% and CD31+ blood vessels in the tumor by ~30% (Fig. 1f, g and h). This evidence concerns the gene PECAM1 and breast neoplasm.